Cancer of EXOCRINE pancreas. Common in West+Japan. US: 2nd MC alimentary tract cancer after colorectal, ↑African Americans, 5% of all cancer deaths. More common MALES, ↑incidence after age 50.
↑incidence UK/US last 50yrs, poorly understood. Factors:
KEY CONTRAST: alcohol, coffee, cholelithiasis = NOT risk factors (unlike acute pancreatitis where alcohol+gallstones=80% of cases — different risk profiles despite both pancreatic diseases). K-RAS + CDKN2A mutation combo = almost ALL cases (unusually consistent molecular signature).
Commonest: HEAD (70%) > body > tail.
Gross: Head=small, homogeneous, poorly-defined, grey-white, no sharp demarcation. Extends into ampulla/CBD/duodenum→EARLY obstructive jaundice (location dictates presentation timing). Body/tail=large, irregular, infiltrates transverse colon/stomach/liver/spleen/nodes.
Micro: mostly from DUCTAL epithelium (<4% of pancreatic cells but source of most cancers); acinar carcinoma <1%. Patterns:
DISMAL — median survival 6 months. ~10% survive 1yr. 5yr survival 1-2%.
Head location→EARLY jaundice = anatomic proximity to ampulla/CBD explains presentation timing, NOT tumour biology — head tumours present earlier despite similar biology to body/tail. Alcohol/coffee/cholelithiasis NON-association = deliberately contrast against acute pancreatitis’s opposite profile (alcohol+gallstones=80%) — frequent confusion source. Perineural invasion = diagnostic-of-malignancy histologic fact, distinguishes malignant ductal CA from benign/reactive changes when differentiation grade ambiguous. Trousseau’s syndrome = classic pancreatic CA paraneoplastic trigger. K-RAS+CDKN2A near-universal combo = unusually consistent tumour genetics vs heterogeneous profiles in most other cancers.
Cancer of EXOCRINE pancreas. Common in West+Japan. US: 2nd MC alimentary tract cancer after colorectal, ↑African Americans, 5% of all cancer deaths. More common MALES, ↑incidence after age 50.
↑incidence UK/US last 50yrs, poorly understood. Factors:
KEY CONTRAST: alcohol, coffee, cholelithiasis = NOT risk factors (unlike acute pancreatitis where alcohol+gallstones=80% of cases — different risk profiles despite both pancreatic diseases). K-RAS + CDKN2A mutation combo = almost ALL cases (unusually consistent molecular signature).
Commonest: HEAD (70%) > body > tail.
Gross: Head=small, homogeneous, poorly-defined, grey-white, no sharp demarcation. Extends into ampulla/CBD/duodenum→EARLY obstructive jaundice (location dictates presentation timing). Body/tail=large, irregular, infiltrates transverse colon/stomach/liver/spleen/nodes.
Micro: mostly from DUCTAL epithelium (<4% of pancreatic cells but source of most cancers); acinar carcinoma <1%. Patterns:
DISMAL — median survival 6 months. ~10% survive 1yr. 5yr survival 1-2%.
Head location→EARLY jaundice = anatomic proximity to ampulla/CBD explains presentation timing, NOT tumour biology — head tumours present earlier despite similar biology to body/tail. Alcohol/coffee/cholelithiasis NON-association = deliberately contrast against acute pancreatitis’s opposite profile (alcohol+gallstones=80%) — frequent confusion source. Perineural invasion = diagnostic-of-malignancy histologic fact, distinguishes malignant ductal CA from benign/reactive changes when differentiation grade ambiguous. Trousseau’s syndrome = classic pancreatic CA paraneoplastic trigger. K-RAS+CDKN2A near-universal combo = unusually consistent tumour genetics vs heterogeneous profiles in most other cancers.
Pancreatic cancer refers to cancer of the exocrine pancreas. One of the common cancers, particularly in Western countries and Japan. In the US, it is the second most common alimentary tract cancer after colorectal cancer, more common in African Americans, and accounts for 5% of all cancer deaths there. More common in males; incidence rises progressively after age 50.
Incidence has significantly risen in the UK and US over the last 50 years; etiology remains poorly understood, but several factors are implicated:
Notably, excessive alcohol or coffee consumption and cholelithiasis are NOT risk factors for pancreatic cancer (a genuine contrast with acute pancreatitis’s etiology). A combination of K-RAS gene and CDKN2A gene mutations is found in almost all cases.
Commonest location: head of pancreas (70%), then body and tail in decreasing frequency.
Gross: carcinoma of the head — small, homogeneous, poorly-defined, grey-white mass without sharp demarcation from surrounding parenchyma; extends into the ampulla of Vater, common bile duct, and duodenum, producing obstructive biliary symptoms and jaundice early in the disease course. Carcinomas of the body/tail — fairly large, irregular masses, frequently infiltrating the transverse colon, stomach, liver, spleen, and regional lymph nodes.
Micro: most pancreatic carcinomas arise from ductal epithelium (despite comprising <4% of total pancreatic cells); acinar-cell carcinoma accounts for <1% of pancreatic cancers. Histologic patterns:
Symptoms depend on tumour location:
Dismal — median survival 6 months from diagnosis; ~10% survive 1 year; 5-year survival only 1–2%.
Pancreatic cancer refers to cancer of the exocrine pancreas. One of the common cancers, particularly in Western countries and Japan. In the US, it is the second most common alimentary tract cancer after colorectal cancer, more common in African Americans, and accounts for 5% of all cancer deaths there. More common in males; incidence rises progressively after age 50.
Incidence has significantly risen in the UK and US over the last 50 years; etiology remains poorly understood, but several factors are implicated:
Notably, excessive alcohol or coffee consumption and cholelithiasis are NOT risk factors for pancreatic cancer (a genuine contrast with acute pancreatitis’s etiology). A combination of K-RAS gene and CDKN2A gene mutations is found in almost all cases.
Commonest location: head of pancreas (70%), then body and tail in decreasing frequency.
Gross: carcinoma of the head — small, homogeneous, poorly-defined, grey-white mass without sharp demarcation from surrounding parenchyma; extends into the ampulla of Vater, common bile duct, and duodenum, producing obstructive biliary symptoms and jaundice early in the disease course. Carcinomas of the body/tail — fairly large, irregular masses, frequently infiltrating the transverse colon, stomach, liver, spleen, and regional lymph nodes.
Micro: most pancreatic carcinomas arise from ductal epithelium (despite comprising <4% of total pancreatic cells); acinar-cell carcinoma accounts for <1% of pancreatic cancers. Histologic patterns:
Symptoms depend on tumour location:
Dismal — median survival 6 months from diagnosis; ~10% survive 1 year; 5-year survival only 1–2%.
Personal revision notes, mnemonics and reminders.
